2 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
Follow Hepatitis D: new trials by email Literature Review of Hepatitis D trials Research Report on Hepatitis D
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Safety and Efficacy of ATI-2173 in Combination With Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis B Virus Infection and in Subjects With Hepatitis D Virus Coinfection ATI-2173, Viread, AB-729 - Hepatitis B, Chronic, Hepatitis D | Phase 2 | Terminated | Antios Therapeutics, Inc | 40 | 2021-03-30 | 2022-11-18 |
| Study of ARC-520 With or Without Other Drugs Used in the Treatment of Chronic Chronic Hepatitis B Virus (HBV) ARC-520, entecavir, pegylated interferon alpha 2a - Hepatitis B, Hepatitis D | Phase 2 | Terminated | Arrowhead Pharmaceuticals | 79 | 2015-12-01 | 2026-01-13 |
Hepatitis B (1) · Hepatitis B, Chronic (1)
Blood-Borne Infections (2) · Communicable Diseases (2) · DNA Virus Infections (2) · Digestive System Diseases (2) · Hepadnaviridae Infections (2) · Hepatitis (2) · Hepatitis, Viral, Human (2) · Infections (2) · Liver Diseases (2) · RNA Virus Infections (2) · Virus Diseases (2) · Chronic Disease (1) · Disease Attributes (1) · Hepatitis B (1) · Hepatitis, Chronic (1)
Tenofovir (2) · ARC-520 (1) · Histamine Antagonists (1) · entecavir (1) · peginterferon alfa-2a (1)
Antios Therapeutics, Inc (1) · Arrowhead Pharmaceuticals (1)
Moldova (2) · Australia (1) · Bulgaria (1) · China (1) · New Zealand (1) · South Korea (1) · Taiwan (1) · Thailand (1) · Ukraine (1)
2015 (1)